Literature DB >> 7033816

The use of dopamine agonists in the treatment of schizophrenia.

G U Corsini, G F Pitzalis, F Bernardi, A Bocchetta, M Del Zompo.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7033816

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


× No keyword cloud information.
  10 in total

Review 1.  Apomorphine and the dopamine hypothesis of schizophrenia: a dilemma?

Authors:  L Dépatie; S Lal
Journal:  J Psychiatry Neurosci       Date:  2001-05       Impact factor: 6.186

Review 2.  GPCR functional selectivity has therapeutic impact.

Authors:  Richard B Mailman
Journal:  Trends Pharmacol Sci       Date:  2007-07-13       Impact factor: 14.819

Review 3.  [Apomorphine in the treatment of Parkinson's Disease].

Authors:  D Dressler
Journal:  Nervenarzt       Date:  2005-06       Impact factor: 1.214

4.  Subcutaneous apomorphine in the treatment of Parkinson's disease.

Authors:  J P Frankel; A J Lees; P A Kempster; G M Stern
Journal:  J Neurol Neurosurg Psychiatry       Date:  1990-02       Impact factor: 10.154

5.  Methylphenidate, apomorphine, THIP, and diazepam in monkeys: dopamine-GABA behavior related to psychoses and tardive dyskinesia.

Authors:  J Gerlach; N Bjørndal; E Christensson
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

Review 6.  Dopamine receptor agonists: mechanisms underlying autoreceptor selectivity. II. Theoretical considerations.

Authors:  D Clark; S Hjorth; A Carlsson
Journal:  J Neural Transm       Date:  1985       Impact factor: 3.575

Review 7.  Third generation antipsychotic drugs: partial agonism or receptor functional selectivity?

Authors:  Richard B Mailman; Vishakantha Murthy
Journal:  Curr Pharm Des       Date:  2010       Impact factor: 3.116

8.  Pharmacologic properties of (-)-3PPP (preclamol) in man.

Authors:  C A Tamminga; N G Cascella; R A Lahti; M Lindberg; A Carlsson
Journal:  J Neural Transm Gen Sect       Date:  1992

9.  Effects of (-)3-PPP on acquisition and retention of a conditioned avoidance response in the rat.

Authors:  S Ahlenius; T Archer; B Tandberg; V Hillegaart
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

Review 10.  Dopamine receptor signaling and current and future antipsychotic drugs.

Authors:  Kevin N Boyd; Richard B Mailman
Journal:  Handb Exp Pharmacol       Date:  2012
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.